The following reports are published and available for immediate shipment.
Please contact Al Doig at adoig@healthtech.com to suggest topics to be updated or new topics to be covered in the area of pharmaceutical drug discovery and development.
2002/03/04 Reports
The following reports are available for purchase in PDF format only for $1,500.00.
For a table of contents, please contact Rose LaRaia at
rlaraia@healthtech.com.
Successful Pharmacogenomics Business Models
Molecular Diagnostics: Technological Advances Fueling Market Expansion
Post-Genomic Target Validation: Next Generation Approaches and Tools for Optimizing Target Selection
Cancer Genomics: Revolutionizing Treatment and Reshaping Markets through Targeted Therapies
Kinases: From Targets to Therapeutics
GPCRs: Mining the Richest Vein in Drug Discovery
Advances in Lead Optimization Accelerating Drug Discovery and Development
Life Sciences Informatics: From Data to Drugs
Proteomics Survey Report 2003
Targeting RNA in Drug Development: Emerging Tools and Therapeutics
Prospects for the Commercialization of Human Monoclonal Antibodies
High-Content Screening: Parallel Analysis Fuels Accelerated Discovery and Development
Outlook for DNA Microarrays: Emerging Applications and Insight on Optimizing Microarray Studies
Predictive Pharmacogenomics: Revolutionizing Health Care
Toxicogenomics and Related Approaches: The Promise of Safer, Smarter Drug Development
Biochemical Pathway and Systems Analysis for Target Identification and Validation